Daiichi Sankyo and Alteogen Sign $300 Million Deal to Develop Subcutaneous Enhertu
Daiichi Sankyo (TYO: 4568), a leading Japanese pharmaceutical company, has entered into a potentially $300...
Daiichi Sankyo (TYO: 4568), a leading Japanese pharmaceutical company, has entered into a potentially $300...
China-based gene sequencing specialist, MGI Tech Co., Ltd, (SHA: 688114) has announced a commercial collaboration...
Jiangsu Kanion Pharmaceutical Co., Ltd (SHA: 600557), a China-based pharmaceutical company, has announced its intention...
Nuwacell Biotechnologies Co., Ltd., a specialist in induced pluripotent stem cell (iPSC) technology based in...
Shanghai Henlius Biotech Inc. (HKG: 2696), a leading Chinese biotech company, has entered into a...
Israel based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced new partnerships with Chinese firms...
Bayer (ETR: BAYN) has announced that its China Prescription Medicines business has fully adopted the...
Shanghai Pharmaceuticals Holding Co., Ltd’s (HKG: 2607, SHA: 601607) subsidiary, MediTrust Health, which specializes in...
Boehringer Ingelheim, a leading German pharmaceutical company, has entered into a strategic partnership with Wuhan...
Hainan Haiyao Co., Ltd (SHE: 000566), a prominent Chinese company, has announced the signing of...
China-based Nanjing Leads Biolabs Co., Ltd and venture capital firm Aditum Bio have announced the...
French pharmaceutical giant Sanofi (NASDAQ: SNY) has signed a partnership deal with Cathay Capital, a...
At the 7th China International Import Expo (CIIE), Japan-based Eisai Co., Ltd (TYO: 4523) entered...
Lohmann & Rauscher, a medical group with headquarters in Germany and Austria, has entered into...
At the 7th China International Import Expo (CIIE), China-based Shanghai Pharmaceutical Co., Ltd (SPH, SHA:...
German pharmaceutical giant Bayer HealthCare (FRA: BAYN) has entered into a partnership agreement with the...
US-Irish firm Medtronic (NYSE: MDT) has entered into a partnership with China-based China Resources Guangdong...
At the 7th China International Import Expo (CIIE), Swiss pharmaceutical giant Novartis (NYSE: NVS) announced...
Vantive, a planned spin-off from U.S.-based Baxter International (NYSE: BAX) specializing in kidney care, has...
China-based Northeast Pharmaceutical Co., Ltd (SHE: 000597) has announced its intention to acquire a 70%...